COVID-19 Vaccine Recommendation
This is a KP.2 news story, published by CityNews, that relates primarily to RSVpreF news.
KP.2 news
For more KP.2 news, you can click here:
more KP.2 newsRSVpreF news
For more RSVpreF news, you can click here:
more RSVpreF newsNews about vaccine development
For more vaccine development news, you can click here:
more vaccine development newsCityNews news
For more news from CityNews, you can click here:
more news from CityNewsAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like this article about vaccine development, you might also like this article about
latest available vaccine. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest new vaccine news, several vaccines news, news about vaccine development, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
yearly flu shot scheduleCityNews
•Doctors advise adding COVID-19 to your list of vaccines this cold and flu season
70% Informative
COVID-19 vaccines are optimized for XBB 1.5 mutation of the Omicron strain that emerged last year .
New variants named KP.2 and JN.1 have since emerged and vaccines need to be adjusted accordingly.
People over 65, people with underlying medical conditions that put them at greater risk for severe infection.
RSV can be more severe for older adults and two vaccines are available RSVPreF3 (Arexvy) and RSVpreF ( Abrysvo ) RSV pre-F vaccine Abrysvo is recommended for pregnant mothers.
For infants, RSV protection comes in the form of monoclonal antibody preparations nirsevimab and palivizumab.
VR Score
60
Informative language
52
Neutral language
44
Article tone
informal
Language
English
Language complexity
48
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
3
Source diversity
2
Affiliate links
no affiliate links